# LifeMine funding rounds and investors

As of 14 Oct 2026, LifeMine has raised $188M across 1 verified round on record; latest: $188 million Series E led by Milky Way Investments, announced 6 Aug 2026.

LifeMine is a clinical-stage biopharmaceutical company that develops next-generation precision medicines through an innovative drug discovery approach focused on evolutionary insights from fungi, targeting patients in need of breakthrough therapies.

Website: https://lifeminetx.com  
Headquarters: Watertown, Massachusetts  
Page: https://fireround.dev/companies/lifeminetx.com

## Verified rounds

| Announced | Round | Amount | Lead investors | Other investors | Sources |
| --- | --- | --- | --- | --- | --- |
| 2026-08-06 | Series E | $188 million | Milky Way Investments | Arch Venture Partners, Bezos Expeditions, Gates Frontier, GSK, GV (Google Ventures), Invus, LoLa Capital Partners, RA Capital Management | [mgmtboston.com](https://mgmtboston.com/news/lifemine-263m-series-e-bezos-gates) |

Source: Fireround (https://fireround.dev), an open-source funding feed. Each round is checked against the pages listed with it.